仁和药业(000650.SZ)：仁和集团拟减持不超过300万股

Core Viewpoint - Renhe Pharmaceutical (000650.SZ) announced a plan for its parent company, Renhe (Group) Development Co., Ltd., to reduce its shareholding by up to 3,000,000 shares, representing a maximum of 0.2143% of the total share capital within three months after the announcement [1] Summary by Sections - Share Reduction Plan - The reduction will be executed through centralized bidding or block trading [1] - The plan will be implemented within three months from the announcement date, starting 15 trading days after the disclosure [1] - Adjustment Clause - If any corporate actions such as stock dividends, capital increases, new share issuance, or rights issues occur during the reduction period, the number of shares to be reduced will be adjusted accordingly, while maintaining the same percentage of total share capital [1]